News

The deal gives Luye the rights to Seroquel and Seroquel XR in the UK, China and other international markets, including Brazil, Australia, Saudi Arabia, Mexico, South Korea, Thailand,

The portfolio primarily consists of oral solutions with a few semi-solid products.  For the 12 months ended March 2018, combined sales of the acquired products were in excess

As a diversified company with a robust generics business, Amneal is now the 5th largest generics business in the United States, with a growing, high-margin specialty franchise. Shares

The US Food and Drug Administration (FDA), which accepted the company’s supplemental Biologics License Application (sBLA), gave the designation for the combination to be used as first-line treatment

The oral formulation of cobitolimod is a potential follow-on product to the topical formulation, which is currently being investigated in the CONDUCT study – a phase IIb dose

In its inaugural year, the Pathways program will support research projects focused on helping those living with substance use disorders (SUD), including those relating to the use of

The approval is for patients in whom the tumor cannot be removed by surgery or has spread to other parts of the body, and has the abnormal gene,

Horizon secured an unsolicited and highly conditional proposal from Abcam. Abcam has offered £1.81 per Horizon share, which represents a premium of only 25.7% to its share on 1

monARC's multi-disciplinary team of drug developers and technology experts have built disease-specific patient network applications and online tools that prequalify and engage patients during protocol development prior to